Understanding Your Wegovy vs Mounjaro Dosage Options
Wegovy vs Mounjaro Dosage: Starting Your Weight Management Journey
When comparing Wegovy vs Mounjaro dosage requirements, the fundamental difference lies in their starting protocols and active mechanisms. Wegovy begins with a gentle 0.25mg dose for the first four weeks, designed to help your body gradually adjust to semaglutide while minimising potential side effects like nausea or digestive discomfort. This cautious approach reflects the medication's GLP-1 receptor agonist action, which mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals.
Mounjaro takes a different approach with its 2.5mg starting dose of tirzepatide, a dual GIP and GLP-1 receptor agonist that works on two hormone pathways simultaneously. The higher starting dose reflects tirzepatide's different pharmacological profile and tolerability characteristics. Both medications require prescription-only access through clinical assessment, ensuring your chosen treatment aligns with your medical history, current health status, and weight management goals alongside a reduced-calorie diet and increased physical activity.
Pricing and Value: Wegovy vs Mounjaro Dosage Costs
The Wegovy vs Mounjaro dosage comparison extends to pricing structures that reflect each medication's unique titration schedule. Wegovy's 0.25mg starter dose costs £79.99 as a single pen, with new customers applying code FIRST40 at checkout to reach this final price. Our Intro Duo bundle combines the 0.25mg and 0.5mg doses for £169.99, providing your first two months of treatment through one convenient order. Returning customers benefit from code DOSE25 for ongoing supplies.
For those preferring a gradual approach, our Gentle Start Trio includes 0.25mg, 0.25mg, and 0.5mg doses for £269.99, allowing extended time at the initial dose if needed for tolerance. The complete 16-week escalation programme progresses through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), reaching maintenance 2.4mg (£209.99). All pricing includes our clinical assessment, prescriber review, and next-day cold-chain delivery once approved by our registered healthcare professionals.
Clinical Evidence: Wegovy vs Mounjaro Dosage Effectiveness
The STEP clinical trial programme demonstrates Wegovy's effectiveness when following the prescribed dosage escalation schedule. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. The recent SELECT trial showed a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management for eligible patients.
Mounjaro's clinical evidence comes from the SURMOUNT trials, though direct comparison of trial results isn't appropriate due to different study designs, patient populations, and endpoints. Both medications demonstrate efficacy when used as prescribed alongside lifestyle modifications, with individual responses varying based on multiple factors including adherence to dosing schedules, dietary changes, and physical activity levels.
How Wegovy Works: Understanding GLP-1 Mechanism
Wegovy's active ingredient semaglutide functions as a GLP-1 receptor agonist, mimicking a hormone naturally produced in your intestines when you eat. This mechanism helps reduce appetite by acting on brain centres that control hunger and satiety, potentially making you feel fuller after consuming smaller portions. The gradual dose escalation from 0.25mg allows your body to adapt to these hormonal changes whilst minimising side effects. Unlike Mounjaro's dual-pathway approach targeting both GLP-1 and GIP receptors, Wegovy focuses specifically on GLP-1 pathways. This targeted action may help reduce food cravings and support portion control when combined with nutritional planning and regular physical activity as part of your comprehensive weight management programme.
Ordering Process: Getting Started with Wegovy vs Mounjaro
Both Wegovy and Mounjaro require identical ordering processes through EverydayMeds' regulated pathway. Your journey begins with our 3-minute online clinical assessment, covering medical history, current medications, and weight management goals to determine suitability. Our registered prescribers review applications within 3 working days (or 24 hours with express service), ensuring thorough evaluation before approval. Once approved, your chosen medication ships via next-day delivery using specialist cold-chain packaging to maintain optimal temperature throughout transit. Our GPhC-registered pharmacy (#9012878) sources all medications directly from licensed wholesalers, guaranteeing authenticity and proper handling. Both treatments arrive with comprehensive patient information leaflets and injection guidance to support your first dose experience.
Storage and Practical Considerations: Wegovy vs Mounjaro Dosage Handling
Storage requirements present a practical advantage when comparing Wegovy vs Mounjaro dosage management for active lifestyles. Wegovy pens maintain potency for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require initial refrigerated storage at 2-8°C before first use, with the FlexTouch pen design providing user-friendly injection experience. The 16-week Wegovy escalation schedule means changing pen strengths monthly, whilst Mounjaro follows its own titration timeline, making dose tracking essential for both treatments. Neither medication should be frozen or exposed to direct sunlight, and used pens should be disposed of safely through pharmacy take-back programmes or appropriate sharps containers.
First Month Expectations: Wegovy vs Mounjaro Dosage Adaptation
The initial weeks present different experiences when comparing Wegovy vs Mounjaro dosage effects on your daily routine. Wegovy's 0.25mg starting dose typically produces subtle changes—you might notice reduced appetite between meals, feeling satisfied with smaller portions, or decreased interest in high-calorie snacks. Some patients experience mild nausea during the first week, usually manageable by taking the injection before bedtime and eating smaller, more frequent meals.
Both medications work best when integrated into structured lifestyle changes from day one. The prescription-only nature ensures ongoing medical supervision throughout your adaptation period. Your prescriber may recommend staying longer at the 0.25mg dose if side effects occur, emphasising that successful weight management prioritises tolerability and sustainable habits over rapid progression through the dosage schedule.
Making Your Decision: Wegovy vs Mounjaro Dosage Selection
The choice between Wegovy and Mounjaro involves multiple factors beyond simple dosage comparison, including individual medical history, lifestyle preferences, and treatment goals. Both prescription-only medicines are available from EverydayMeds, with your prescriber helping determine which option aligns best with your circumstances. Wegovy's proven track record spans over four years of real-world use, whilst Mounjaro represents newer dual-pathway technology with its own emerging evidence base. Cost considerations, storage requirements, and injection frequency all influence long-term treatment sustainability. Your clinical assessment explores these factors comprehensively, ensuring informed decision-making supported by professional medical guidance throughout your weight management journey with either treatment option.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
